[Rapid sequence induction in pediatric patients--a questionnaire survey to the children's hospitals in Japan]

Kazuya Tachibana1, Keiko Kinouchi, Muneyuki Takeuchi

  • 1Department of Anesthesia and Intensive Care, Osaka Medical Center and Research Institute for Maternal and Child Health, Izumi 594-1101.

Masui. the Japanese Journal of Anesthesiology
|May 18, 2012
PubMed

Insights

Rapid sequence induction practices for pediatric full stomach cases in Japan vary. Procedures differ based on patient age and condition, highlighting the need for tailored approaches in pediatric anesthesia.

Area of Science:

  • Pediatric Anesthesiology
  • Critical Care Medicine
  • Surgical Patient Management

Context:

  • Rapid sequence induction (RSI) is a critical procedure for preventing aspiration in patients with a full stomach.
  • Limited data exists on current RSI practices for pediatric patients with full stomachs in Japanese children's hospitals.
  • Understanding these practices is essential for standardizing care and improving patient safety.

Purpose:

  • To investigate and detail the current practices of rapid sequence induction in Japanese children's hospitals for two distinct full stomach scenarios.
  • To compare RSI methods used for a 4-week-old infant with pyloric stenosis versus a 3-year-old child with ileus.
  • To identify variations and commonalities in anesthetic management for these high-risk pediatric cases.

Summary:

  • A survey of 17 out of 27 pediatric anesthesia departments revealed consistent use of nasogastric tube insertion and suction prior to induction.
  • Atropine use and gentle mask ventilation were more common in the infant (pyloric stenosis) scenario.
  • Awake intubation was not employed, and cricoid pressure use was low (24%) in infants, indicating diverse approaches to RSI in pediatric full stomach cases.

Impact:

  • This study provides the first detailed overview of RSI practices for full stomach pediatric patients in Japan.
  • Findings highlight that anesthetic management for RSI in children is adapted based on age, specific disease, and clinical condition.
  • The results can inform the development of evidence-based guidelines and enhance the safety of pediatric anesthesia in Japan and potentially other regions.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...